phase readout
saveNCT07136103: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: AbbVie. Phase: PHASE1. Conditions: Healthy Volunteers
view source ↗
comments(0)
5-min edit window · permanent after that